{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:30:02Z","timestamp":1777937402154,"version":"3.51.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Schleswig-Holstein - Campus Kiel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Traumeel (Tr14) and diclofenac gels are commonly prescribed topical treatments for Grade I-II acute lateral ankle sprain (LAS). A meta-analysis of two multi-center trials was performed to compare their clinical efficacy and supplement the evidence in support of topical treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from two Phase III prospective, randomised, double-blind, reference-controlled clinical trials, TAASS (2013) and TRAUMED (2024) were examined. An Individual Patient Data (IPD) meta-analysis was performed on those with an initial pain VAS (Visual Analogue Scale) score \u2265\u200950\u00a0mm, using the statistical analysis plan from the latter to ensure methodological consistency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 628 patients underwent meta-analysis (mean baseline pain VAS\u2009=\u200972.3, mean age\u2009=\u200932.5). The primary endpoint of the IPD meta-analysis, Area Under the Curve (AUC) of pain VAS scores, indicated beneficial effects of Tr14 gel compared with diclofenac gel, statistically significant on Days 4, 7, and 14 (Day 4 mean difference MD\n                      <jats:sub>AUC-META<\/jats:sub>\n                      = -6.9 [95%CI -13.7 to -0.1], P\n                      <jats:sub>AUC-META<\/jats:sub>\n                      = 0.05; Day 7 MD\n                      <jats:sub>AUC-META<\/jats:sub>\n                      = -26.3 [95%CI -40.4 to -12.2], P\n                      <jats:sub>AUC-META<\/jats:sub>\n                      = 0.0003; Day 14 MD\n                      <jats:sub>AUC-META<\/jats:sub>\n                      = -63.6 [95%CI -92.3 to -34.8]), P\n                      <jats:sub>AUC-META<\/jats:sub>\n                      &lt; 0.0001). A robust Wilcoxon-Mann-Whitney (WMW) analysis revealed percent changes from baseline in pain and function that were significantly superior for Tr14 gel in the pre-planned method of synthesis, compared to diclofenac gel, on all days (all PMETA\u2009&lt;\u20090.05). Finally, translational effect sizes indicated less than \u201csmall\u201d superiority on Day 4 (SMD 0.15, OR 0.78, NNT 23), and \u201csmall-medium-sized\u201d superiority on Days 7 and 14 (Day 7: SMD 0.31, OR 0.59, NNT 12; Day 14: SMD 0.37, OR 0.53, NNT 10) for pain measured by VAS, as compared to diclofenac gel.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The IPD meta-analysis of the TAASS and TRAUMED trials confirms the efficacy of Tr14 gel. In-depth analysis reveals it is a statistically favourable treatment with respect to pain, and function, compared to the gold-standard diclofenac gel. Taking this together, Tr14 gel represents a statistically favourable treatment option for Grade I\u2013II ankle sprain within the context of the analysed endpoints.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-026-09802-0","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:14:12Z","timestamp":1777626852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tr14 gel compared to diclofenac gel after acute unilateral ankle sprain: an Individual Patient Data (IPD) meta-analysis of two multi-center trials"],"prefix":"10.1186","volume":"27","author":[{"given":"J.","family":"Vester","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gerdesmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kerkhoffs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"9802_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.5312\/wjo.v11.i12.534","volume":"11","author":"F Halabchi","year":"2020","unstructured":"Halabchi F, Hassabi M. Acute ankle sprain in athletes: Clinical aspects and algorithmic approach. World J Orthop. 2020;11:534\u201358. https:\/\/doi.org\/10.5312\/wjo.v11.i12.534.","journal-title":"World J Orthop"},{"key":"9802_CR2","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/bjsports-2016-096189","volume":"50","author":"PA Gribble","year":"2016","unstructured":"Gribble PA, Bleakley CM, Caulfield BM, Docherty CL, Fourchet F, Fong DT-P, Hertel J, Hiller CE, Kaminski TW, McKeon PO, et al. Evidence review for the 2016 International Ankle Consortium consensus statement on the prevalence, impact and long-term consequences of lateral ankle sprains. Br J Sports Med. 2016;50:1496\u2013505. https:\/\/doi.org\/10.1136\/bjsports-2016-096189.","journal-title":"Br J Sports Med"},{"key":"9802_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.fcl.2022.12.002","volume":"28","author":"CC Hong","year":"2023","unstructured":"Hong CC, Calder J. The Burden of the Simple Ankle Sprains: A Review of the Epidemiology and Long-Term Impact. Foot Ankle Clin. 2023;28:187\u2013200. https:\/\/doi.org\/10.1016\/j.fcl.2022.12.002.","journal-title":"Foot Ankle Clin"},{"key":"9802_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.amjmed.2007.11.018","volume":"121","author":"RM van Rijn","year":"2008","unstructured":"van Rijn RM, van Os AG, Bernsen RM, Luijsterburg PA, Koes BW, Bierma-Zeinstra SM. What is the clinical course of acute ankle sprains? A systematic literature review. Am J Med. 2008;121:324\u2013e331326. https:\/\/doi.org\/10.1016\/j.amjmed.2007.11.018.","journal-title":"Am J Med"},{"key":"9802_CR5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2106\/jbjs.I.01537","volume":"92","author":"BR Waterman","year":"2010","unstructured":"Waterman BR, Owens BD, Davey S, Zacchilli MA, Belmont PJ. Jr. The epidemiology of ankle sprains in the United States. J Bone Joint Surg Am. 2010;92:2279\u201384. https:\/\/doi.org\/10.2106\/jbjs.I.01537.","journal-title":"J Bone Joint Surg Am"},{"key":"9802_CR6","unstructured":"Struijs PA, Kerkhoffs GM. Ankle sprain. BMJ Clin Evid 2010, 2010."},{"key":"9802_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/00913847.2019.1581511","volume":"47","author":"K Song","year":"2019","unstructured":"Song K, Wikstrom EA. Plausible mechanisms of and techniques to assess ankle joint degeneration following lateral ankle sprains: a narrative review. Phys Sportsmed. 2019;47:275\u201383. https:\/\/doi.org\/10.1080\/00913847.2019.1581511.","journal-title":"Phys Sportsmed"},{"key":"9802_CR8","doi-asserted-by":"publisher","first-page":"e069867","DOI":"10.1136\/bmjopen-2022-069867","volume":"13","author":"J Wagemans","year":"2023","unstructured":"Wagemans J, Taeymans J, Kuppens K, Baur H, Bleakley C, Vissers D. Determining key clinical predictors for chronic ankle instability and return to sports with cost of illness analysis: protocol of a prospective cohort study. BMJ Open. 2023;13:e069867. https:\/\/doi.org\/10.1136\/bmjopen-2022-069867.","journal-title":"BMJ Open"},{"key":"9802_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0838.2007.00746.x","volume":"18","author":"U Fredberg","year":"2008","unstructured":"Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports. 2008;18:3\u201315. https:\/\/doi.org\/10.1111\/j.1600-0838.2007.00746.x.","journal-title":"Scand J Med Sci Sports"},{"key":"9802_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/0363546516628870","volume":"44","author":"C Doherty","year":"2016","unstructured":"Doherty C, Bleakley C, Hertel J, Caulfield B, Ryan J, Delahunt E. Recovery From a First-Time Lateral Ankle Sprain and the Predictors of Chronic Ankle Instability: A Prospective Cohort Analysis. Am J Sports Med. 2016;44:995\u20131003. https:\/\/doi.org\/10.1177\/0363546516628870.","journal-title":"Am J Sports Med"},{"key":"9802_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s40279-014-0218-2","volume":"44","author":"AS Attenborough","year":"2014","unstructured":"Attenborough AS, Hiller CE, Smith RM, Stuelcken M, Greene A, Sinclair PJ. Chronic ankle instability in sporting populations. Sports Med. 2014;44:1545\u201356. https:\/\/doi.org\/10.1007\/s40279-014-0218-2.","journal-title":"Sports Med"},{"key":"9802_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4085\/1062-6050-474-17","volume":"54","author":"PO McKeon","year":"2019","unstructured":"McKeon PO, Donovan LA. Perceptual Framework for Conservative Treatment and Rehabilitation of Ankle Sprains: An Evidence-Based Paradigm Shift. J Athl Train. 2019;54:628\u201338. https:\/\/doi.org\/10.4085\/1062-6050-474-17.","journal-title":"J Athl Train"},{"key":"9802_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4085\/1062-6050-344-18","volume":"54","author":"J Hertel","year":"2019","unstructured":"Hertel J, Corbett RO. An Updated Model of Chronic Ankle Instability. J Athl Train. 2019;54:572\u201388. https:\/\/doi.org\/10.4085\/1062-6050-344-18.","journal-title":"J Athl Train"},{"key":"9802_CR14","doi-asserted-by":"publisher","unstructured":"Ghosh N, Kolade OO, Shontz E, Rosenthal Y, Zuckerman JD, Bosco JA 3rd;, Virk MS. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Their Effect on Musculoskeletal Soft-Tissue Healing: A Scoping Review. JBJS Rev. 2019;7:e4. https:\/\/doi.org\/10.2106\/JBJS.RVW.19.00055.","DOI":"10.2106\/JBJS.RVW.19.00055"},{"key":"9802_CR15","first-page":"S3","volume":"19","author":"JW Atchison","year":"2013","unstructured":"Atchison JW, Herndon CM, Rusie E. NSAIDs for musculoskeletal pain management:current perspectives and novel strategies to improve safety. J Manag Care Pharm. 2013;19:S3\u201319.","journal-title":"J Manag Care Pharm"},{"key":"9802_CR16","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s11999-013-3258-2","volume":"472","author":"BK Connizzo","year":"2014","unstructured":"Connizzo BK, Yannascoli SM, Tucker JJ, Caro AC, Riggin CN, Mauck RL, Soslowsky LJ, Steinberg DR, Bernstein J. The detrimental effects of systemic Ibuprofen delivery on tendon healing are time-dependent. Clin Orthop Relat Res. 2014;472:2433\u20139. https:\/\/doi.org\/10.1007\/s11999-013-3258-2.","journal-title":"Clin Orthop Relat Res"},{"key":"9802_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00402-014-2099-0","volume":"134","author":"H Cabuk","year":"2014","unstructured":"Cabuk H, Avci A, Durmaz H, Cabuk FK, Ertem F, Muhittin \u015eener I. The effect of diclofenac on matrix metalloproteinase levels in the rotator cuff. Arch Orthop Trauma Surg. 2014;134:1359\u2013744. https:\/\/doi.org\/10.1007\/s00402-014-2099-0.","journal-title":"Arch Orthop Trauma Surg"},{"key":"9802_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/01.lab.0000078688.07696.ac","volume":"83","author":"D Marsolais","year":"2003","unstructured":"Marsolais D, C\u00f4t\u00e9 CH, Frenette J. Nonsteroidal anti-inflammatory drug reduces neutrophil and macrophage accumulation but does not improve tendon regeneration. Lab Invest. 2003;83:991\u20139. https:\/\/doi.org\/10.1097\/01.lab.0000078688.07696.ac.","journal-title":"Lab Invest"},{"key":"9802_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/bjsports-2017-098106","volume":"52","author":"G Vuurberg","year":"2018","unstructured":"Vuurberg G, Hoorntje A, Wink LM, Van Der Doelen BFW, Van Den Bekerom MP, Dekker R, Van Dijk CN, Krips R, Loogman MCM, Ridderikhof ML, et al. Diagnosis, treatment and prevention of ankle sprains: update of an evidence-based clinical guideline. Br J Sports Med. 2018;52:956\u2013956. https:\/\/doi.org\/10.1136\/bjsports-2017-098106.","journal-title":"Br J Sports Med"},{"key":"9802_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s12630-024-02837-8","volume":"71","author":"D Clinkard","year":"2024","unstructured":"Clinkard D, Buckley N, Diatchenko L, Ghasemlou N. The role of acute inflammation in pain resolution: is it time to rethink the use of routine anti-inflammatories in surgical practice? Can J Anaesth. 2024;71:1349\u201352. https:\/\/doi.org\/10.1007\/s12630-024-02837-8.","journal-title":"Can J Anaesth"},{"key":"9802_CR21","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.3390\/ijms221910370","volume":"22","author":"M Ch\u00e1vez-Castillo","year":"2021","unstructured":"Ch\u00e1vez-Castillo M, Ortega \u00c1, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, et al. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci. 2021;22:10370.","journal-title":"Int J Mol Sci"},{"key":"9802_CR22","doi-asserted-by":"publisher","unstructured":"Wolfarth B, Speed C, Raymuev K, Vanden Bossche L, Migliore A. Managing pain and inflammation associated with musculoskeletal disease: time for a change? Curr Med Res Opin. 2022;1\u20137. https:\/\/doi.org\/10.1080\/03007995.2022.2108618.","DOI":"10.1080\/03007995.2022.2108618"},{"key":"9802_CR23","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3390\/ijms24054342","volume":"24","author":"M Hoch","year":"2023","unstructured":"Hoch M, Rauthe J, Cesnulevicius K, Schultz M, Lescheid D, Wolkenhauer O, Chiurchi\u00f9 V, Gupta S. Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System. Int J Mol Sci. 2023;24:4342.","journal-title":"Int J Mol Sci"},{"key":"9802_CR24","first-page":"110","volume":"22","author":"JF Markworth","year":"2016","unstructured":"Markworth JF, Maddipati KR, Cameron-Smith D. Emerging roles of pro-resolving lipid mediators in immunological and adaptive responses to exercise-induced muscle injury. Exerc Immunol Rev. 2016;22:110\u201334.","journal-title":"Exerc Immunol Rev"},{"key":"9802_CR25","doi-asserted-by":"publisher","first-page":"100894","DOI":"10.1016\/j.mam.2020.100894","volume":"74","author":"CN Serhan","year":"2020","unstructured":"Serhan CN, Gupta SK, Perretti M, Godson C, Brennan E, Li Y, Soehnlein O, Shimizu T, Werz O, Chiurchi\u00f9 V, et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med. 2020;74:100894. https:\/\/doi.org\/10.1016\/j.mam.2020.100894.","journal-title":"Mol Aspects Med"},{"key":"9802_CR26","doi-asserted-by":"publisher","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","volume":"305","author":"JF Markworth","year":"2013","unstructured":"Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR, Cameron-Smith D. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol. 2013;305:R1281\u20131296. https:\/\/doi.org\/10.1152\/ajpregu.00128.2013.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9802_CR27","doi-asserted-by":"publisher","first-page":"eabj9954","DOI":"10.1126\/scitranslmed.abj9954","volume":"14","author":"M Parisien","year":"2022","unstructured":"Parisien M, Lima LV, Dagostino C, El-Hachem N, Drury GL, Grant AV, Huising J, Verma V, Meloto CB, Silva JR, et al. Acute inflammatory response via neutrophil activation protects against the development of chronic pain. Sci Transl Med. 2022;14:eabj9954. https:\/\/doi.org\/10.1126\/scitranslmed.abj9954.","journal-title":"Sci Transl Med"},{"key":"9802_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/ph14111123","volume":"14","author":"PM Jordan","year":"2021","unstructured":"Jordan PM, van Goethem E, M\u00fcller AM, Hemmer K, Gavioli V, Baillif V, Burmeister Y, Kr\u00f6mmelbein N, Dubourdeau M, Seilheimer B, et al. The Natural Combination Medicine Traumeel (Tr14) Improves Resolution of Inflammation by Promoting the Biosynthesis of Specialized Pro-Resolving Mediators. Pharmaceuticals. 2021;14:1123.","journal-title":"Pharmaceuticals"},{"key":"9802_CR29","doi-asserted-by":"publisher","unstructured":"Hoch M, Smita S, Cesnulevicius K, Schultz M, Lescheid D, Wolkenhauer O, Gupta S. Network analyses reveal new insights into the effect of multicomponent Tr14 compared to single-component diclofenac in an acute inflammation model. J Inflamm. 2023;20. https:\/\/doi.org\/10.1186\/s12950-023-00335-0.","DOI":"10.1186\/s12950-023-00335-0"},{"key":"9802_CR30","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/eji.201545818","volume":"45","author":"A Crupi","year":"2015","unstructured":"Crupi A, Costa A, Tarnok A, Melzer S, Teodori L. Inflammation in tissue engineering: The Janus between engraftment and rejection. Eur J Immunol. 2015;45:3222\u201336. https:\/\/doi.org\/10.1002\/eji.201545818.","journal-title":"Eur J Immunol"},{"key":"9802_CR31","doi-asserted-by":"publisher","first-page":"e13393","DOI":"10.1111\/acel.13393","volume":"20","author":"JF Markworth","year":"2021","unstructured":"Markworth JF, Brown LA, Lim E, Castor-Macias JA, Larouche J, Macpherson PCD, Davis C, Aguilar CA, Maddipati KR, Brooks SV. Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling. Aging Cell. 2021;20:e13393. https:\/\/doi.org\/10.1111\/acel.13393.","journal-title":"Aging Cell"},{"key":"9802_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ijcp.12219","volume":"67","author":"C Gonz\u00e1lez de Vega","year":"2013","unstructured":"Gonz\u00e1lez de Vega C, Speed C, Wolfarth B, Gonz\u00e1lez J. Traumeel vs. diclofenac for reducing pain and improving ankle mobility after acute ankle sprain: a multicentre, randomised, blinded, controlled and non-inferiority trial. Int J Clin Pract. 2013;67:979\u201389. https:\/\/doi.org\/10.1111\/ijcp.12219.","journal-title":"Int J Clin Pract"},{"key":"9802_CR33","doi-asserted-by":"publisher","unstructured":"Gerdesmeyer L, Vester J, Schneider C, Wildemann B, Frank C, Schultz M, Seilheimer B, Smit A, Kerkhoffs G. Topical Treatment Is Effective and Safe for Acute Ankle Sprains: The Multi-Center Double-Blind Randomized Placebo-Controlled TRAUMED Trial. J Clin Med. 2024;13. https:\/\/doi.org\/10.3390\/jcm13030841.","DOI":"10.3390\/jcm13030841"},{"key":"9802_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/bjsports-2020-103311","volume":"55","author":"C Bleakley","year":"2021","unstructured":"Bleakley C, Wagemans J, Netterstr\u00f6m-Wedin F. Understanding chronic ankle instability: model rich, data poor. Br J Sports Med. 2021;55:463\u20134. https:\/\/doi.org\/10.1136\/bjsports-2020-103311.","journal-title":"Br J Sports Med"},{"key":"9802_CR35","unstructured":"MEDICINALPRODUCTS CFP, POINTS TO CONSIDER. ON APPLICATION WITH 1. META-ANALYSES. Volume 2. ONE PIVOTAL STUDY; 2021."},{"key":"9802_CR36","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/sim.3165","volume":"27","author":"RD Riley","year":"2008","unstructured":"Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, Boutitie F. Meta-analysis of continuous outcomes combining individual patient data and aggregate data. Stat Med. 2008;27:1870\u201393. https:\/\/doi.org\/10.1002\/sim.3165.","journal-title":"Stat Med"},{"key":"9802_CR37","unstructured":"FDA. Guidance for Industry. Oversight of Clinical Investigations \u2013 A Risk-Based Approach to Monitoring. 2013."},{"key":"9802_CR38","unstructured":"EMA. Reflection paper on risk based quality management in clinical trials. 2011, 1\u201331."},{"key":"9802_CR39","unstructured":"Higgins JPT, Sterne AD JAC,s Chap, Higgins JPT, Chandler CR, Cumpston J MS,s, editors. editor. 8: Assessing risk of bias in included studies. In Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Higgins JPT, Chandler CR, Cumpston J MS,s, editor.; Cochrane: 2017."},{"key":"9802_CR40","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006.","journal-title":"J Clin Epidemiol"},{"key":"9802_CR41","doi-asserted-by":"crossref","unstructured":"Wilcoxon F. Individual comparisons of grouped data by ranking methods. 1946.","DOI":"10.1093\/jee\/39.2.269"},{"key":"9802_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","volume":"18","author":"HB Mann","year":"1947","unstructured":"Mann HB, Whitney DR. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other. Ann Math Stat. 1947;18:50\u201360.","journal-title":"Ann Math Stat"},{"key":"9802_CR43","doi-asserted-by":"publisher","unstructured":"Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Fourth Ed. 2008;760\u201383. https:\/\/doi.org\/10.1002\/9780470773666.refs.","DOI":"10.1002\/9780470773666.refs"},{"key":"9802_CR44","unstructured":"Sprent P. S.N. Applied Nonparametric Statistical Methods, 3 edition,; Chapman and Hall: Boca Raton 2001."},{"key":"9802_CR45","doi-asserted-by":"publisher","unstructured":"D\u2019Agostino R, Campbell M, Greenhouse J. The Mann\u2013Whitney statistic: continuous use and discovery. Stat Med. 2006;25. https:\/\/doi.org\/10.1002\/sim.2508.","DOI":"10.1002\/sim.2508"},{"key":"9802_CR46","doi-asserted-by":"crossref","unstructured":"Rothmann MD, Wiens BL, Chan ISF. Design and Analysis of Non-Inferiority Trials (1st ed.); Chapman and Hall\/CRC.: New York, 2012.","DOI":"10.1201\/b11039-2"},{"key":"9802_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/pst.17","volume":"2","author":"U Munzel","year":"2003","unstructured":"Munzel U, Hauschke D. A nonparametric test for proving noninferiority in clinical trials with ordered categorical data. Pharm Stat. 2003;2:31\u20137. https:\/\/doi.org\/10.1002\/pst.17.","journal-title":"Pharm Stat"},{"key":"9802_CR48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/sim.5634","volume":"32","author":"M Kieser","year":"2013","unstructured":"Kieser M, Friede T, Gondan M. Assessment of statistical significance and clinical relevance. Stat Med. 2013;32:1707\u201319. https:\/\/doi.org\/10.1002\/sim.5634.","journal-title":"Stat Med"},{"key":"9802_CR49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/strokeaha.113.003151","volume":"45","author":"VW Rahlfs","year":"2014","unstructured":"Rahlfs VW, Zimmermann H, Lees KR. Effect size measures and their relationships in stroke studies. Stroke. 2014;45:627\u201333. https:\/\/doi.org\/10.1161\/strokeaha.113.003151.","journal-title":"Stroke"},{"key":"9802_CR50","first-page":"1","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Routledge; 1988. pp. 1\u2013567.","edition":"2"},{"key":"9802_CR51","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1017\/s0266462300007728","volume":"4","author":"GA Colditz","year":"1988","unstructured":"Colditz GA, Miller JN, Mosteller F. Measuring gain in the evaluation of medical technology. The probability of a better outcome. Int J Technol Assess Health Care. 1988;4:637\u201342. https:\/\/doi.org\/10.1017\/s0266462300007728.","journal-title":"Int J Technol Assess Health Care"},{"key":"9802_CR52","unstructured":"EAEMP. ICH Topic E 9: Statistical principles for clinical trials 1998."},{"key":"9802_CR53","unstructured":"Hedges L, Olkin I. Statistical Methods in Meta-Analysis. 1985; Volume 20."},{"key":"9802_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"key":"9802_CR55","unstructured":"Sterne JAC, Moher EM, Boutron D, Chandler JPTCR, Cumpston J MS,s, editors. editor I,s. Chapter 10: Addressing reporting biases. In Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Higgins Chandler JPT,CR, Cumpston J MS,s, editor.; Cochrane 2017: 2017."},{"key":"9802_CR56","doi-asserted-by":"publisher","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H. An Introduction to Meta-Analysis. Introduction Meta-Analysis. 2009;19. https:\/\/doi.org\/10.1002\/9780470743386.","DOI":"10.1002\/9780470743386"},{"key":"9802_CR57","doi-asserted-by":"crossref","unstructured":"Lachin J. Biostatistical Methods: The Assessment of Relative Risks, Second Edition; John Wiley & Sons: 2010.","DOI":"10.1002\/9780470907412"},{"key":"9802_CR58","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/03610929408831302","volume":"23","author":"H Frick","year":"1994","unstructured":"Frick H. A maxmin linear test of normal means and its application to lachin\u2019s data. Commun statistics-theory methods. 1994;23:1021\u20139.","journal-title":"Commun statistics-theory methods"},{"key":"9802_CR59","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/bimj.4710370803","volume":"37","author":"H Frick","year":"1995","unstructured":"Frick H. Comparing Trials with Multiple Outcomes: The Multivariate One-Sided Hypothesis with Unknown Covariances. Biom J. 1995;37:909\u201317.","journal-title":"Biom J"},{"key":"9802_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2307\/2530862","volume":"41","author":"M Gail","year":"1985","unstructured":"Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1985;41:361\u201372.","journal-title":"Biometrics"},{"key":"9802_CR61","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2307\/2533441","volume":"50","author":"P Bauer","year":"1994","unstructured":"Bauer P, K\u00f6hne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994;50:1029\u201341.","journal-title":"Biometrics"},{"key":"9802_CR62","volume-title":"Testing principles in clinical and preclinical trials","author":"W Maurer","year":"1995","unstructured":"Maurer W, Hothorn LA, Lehmacher W. Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollman J, editor. Testing principles in clinical and preclinical trials. Stuttgart: Gustav Fischer; 1995."},{"key":"9802_CR63","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/bjsports-2021-104087","volume":"55","author":"MD Smith","year":"2021","unstructured":"Smith MD, Vicenzino B, Bahr R, Bandholm T, Cooke R, Mendon\u00e7a LDM, Fourchet F, Glasgow P, Gribble PA, Herrington L, et al. Return to sport decisions after an acute lateral ankle sprain injury: introducing the PAASS framework\u2014an international multidisciplinary consensus. Br J Sports Med. 2021;55:1270\u20136. https:\/\/doi.org\/10.1136\/bjsports-2021-104087.","journal-title":"Br J Sports Med"},{"key":"9802_CR64","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4085\/1062-6050-168-20","volume":"56","author":"EA Wikstrom","year":"2021","unstructured":"Wikstrom EA, Cain MS, Chandran A, Song K, Regan T, Migel K, Kerr ZY. Lateral Ankle Sprain and Subsequent Ankle Sprain Risk: A Systematic Review. J Athl Train. 2021;56:578\u201385. https:\/\/doi.org\/10.4085\/1062-6050-168-20.","journal-title":"J Athl Train"},{"key":"9802_CR65","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.foot.2017.04.003","volume":"39","author":"IA Bielska","year":"2019","unstructured":"Bielska IA, Wang X, Lee R, Johnson AP. The health economics of ankle and foot sprains and fractures: A systematic review of English-language published papers. Part 1: Overview and critical appraisal. Foot (Edinb). 2019;39:106\u201314. https:\/\/doi.org\/10.1016\/j.foot.2017.04.003.","journal-title":"Foot (Edinb)"},{"key":"9802_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.foot.2017.07.003","volume":"39","author":"IA Bielska","year":"2019","unstructured":"Bielska IA, Wang X, Lee R, Johnson AP. The health economics of ankle and foot sprains and fractures: A systematic review of English-language published papers. Part 2: The direct and indirect costs of injury. Foot (Edinb). 2019;39:115\u201321. https:\/\/doi.org\/10.1016\/j.foot.2017.07.003.","journal-title":"Foot (Edinb)"},{"key":"9802_CR67","first-page":"2002","volume":"31","author":"PS Tugwell","year":"2004","unstructured":"Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31:2002\u201312.","journal-title":"J Rheumatol"},{"key":"9802_CR68","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/ph3061892","volume":"3","author":"B Nair","year":"2010","unstructured":"Nair B, Taylor-Gjevre RA. Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals (Basel). 2010;3:1892\u2013908. https:\/\/doi.org\/10.3390\/ph3061892.","journal-title":"Pharmaceuticals (Basel)"},{"key":"9802_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1526-4637.2010.00809.x","volume":"11","author":"S Haroutiunian","year":"2010","unstructured":"Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Med. 2010;11:535\u201349. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00809.x.","journal-title":"Pain Med"},{"key":"9802_CR70","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.pmrj.2018.06.011","volume":"10","author":"KM Hatt","year":"2018","unstructured":"Hatt KM, Vijapura A, Maitin IB, Cruz E. Safety Considerations in Prescription of NSAIDs for Musculoskeletal Pain: A Narrative Review. Pm r. 2018;10:1404\u201311. https:\/\/doi.org\/10.1016\/j.pmrj.2018.06.011.","journal-title":"Pm r"},{"key":"9802_CR71","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/joim.13505","volume":"292","author":"CO Stiller","year":"2022","unstructured":"Stiller CO, Hjemdahl P. Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials. J Intern Med. 2022;292:557\u201374. https:\/\/doi.org\/10.1111\/joim.13505.","journal-title":"J Intern Med"},{"key":"9802_CR72","doi-asserted-by":"publisher","unstructured":"Machado GC, Abdel-Shaheed C, Underwood M, Day RO. Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ. 2021;n104. https:\/\/doi.org\/10.1136\/bmj.n104.","DOI":"10.1136\/bmj.n104"},{"key":"9802_CR73","first-page":"96","volume":"106","author":"J Zell","year":"1988","unstructured":"Zell J, Connert WD, Mau J, Feuerstake G. [Treatment of acute sprains of the ankle joint. Double-blind study assessing the effectiveness of a homeopathic ointment preparation]. Fortschr Med. 1988;106:96\u2013100.","journal-title":"Fortschr Med"},{"key":"9802_CR74","first-page":"290","volume":"10","author":"BDA P","year":"1992","unstructured":"P BDA. Treatment of sports injuries with Traumeel ointment: A controlled double-blind study with Traumeel iintment for treatment of sports injuries. Biol Therapy. 1992;10:290\u2013300.","journal-title":"Biol Therapy"},{"key":"9802_CR75","doi-asserted-by":"publisher","first-page":"1366443","DOI":"10.3389\/fnhum.2024.1366443","volume":"18","author":"N Liu","year":"2024","unstructured":"Liu N, Yang C, Song Q, Yang F, Chen Y. Patients with chronic ankle instability exhibit increased sensorimotor cortex activation and correlation with poorer lateral balance control ability during single-leg stance: a FNIRS study. Front Hum Neurosci. 2024;18:1366443. https:\/\/doi.org\/10.3389\/fnhum.2024.1366443.","journal-title":"Front Hum Neurosci"},{"key":"9802_CR76","doi-asserted-by":"publisher","unstructured":"Nozu S, Takemura M, Sole G. Assessments of Sensorimotor Deficits Used in Randomized Clinical Trials With Individuals With Ankle Sprains and Chronic Ankle Instability: A Scoping Review. PM&R. 2020;13. https:\/\/doi.org\/10.1002\/pmrj.12487.","DOI":"10.1002\/pmrj.12487"},{"key":"9802_CR77","unstructured":"Pfizer. NCT01945034 5% Topical Ibuprofen (IBU) for Ankle Sprain Clinicaltrials.gov 2016."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-09802-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-09802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-09802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:00:53Z","timestamp":1777694453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-026-09802-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9802"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-09802-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The purpose of the trials was explained to all participants, supplemented by an information sheet. All participants signed the Informed Consent Form (ICF). Consent for publication is not applicable (due to participating patients being unidentifiable).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"372"}}